JT
CAPR icon

Jupiter Topco’s Capricor Therapeutics CAPR Stock Holding History

Jupiter Topco’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Buy
+22,600
New +$685K ﹤0.01% 2060

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's CAPR Position: Q2 2026 in Review

Jupiter Topco opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 22,600 shares worth $544K. The stake represents ﹤0.01% of the portfolio and ranks #2060 among its holdings.

155 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Jupiter Topco held 22,600 shares of Capricor Therapeutics worth $544K as of Q2 2026.
  • Capricor Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2060 holding.
  • 155 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.